Globus Medical to Showcase SCRIPT™ Patient-Specific Implants and New XLIF™ Prone Procedural Solution at NASS 2026
Key Highlights
- ➤SCRIPT™ patient-specific implant platform previewed as FDA-cleared technology ahead of commercialization
- ➤XLIF™ Prone Solution adds adjustable patient positioner and MaXcess™ Air retractor
- ➤SCRIPT™ Studio integrates surgeon-designed plans with ExcelsiusGPS™ and ExcelsiusHub™ workflows
- ➤Globus Medical showcases spine innovations at NASS 2026 in San Antonio, October 14-17
Expert Statements
Keith Pfeil, President and CEO of Globus Medical
“We believe innovation is most meaningful when it connects technologies across the surgical workflow to support patient-specific planning and coordinated execution. Our focus is on developing an integrated ecosystem that helps surgeons translate their surgical plan in the operating room while supporting the clinical needs of each individual patient”
AUDUBON, Pa., Oct. 14, 2026 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced it will highlight its latest spine innovations at the 41(st) Annual North American Spine Society (NASS) Meeting in San Antonio, Texas, from October 14-17.
Globus Medical is continuing to expand its integrated spine ecosystem with technologies designed to connect patient-specific planning, implant solutions, and surgical execution across a range of spinal procedures. At NASS, the company will showcase SCRIPT™, its new patient-specific spinal implant platform, alongside the new XLIF™ Prone Procedural Solution featuring the XLIF™ Prone Patient Positioner and the MaXcess™ Air two-blade prone lateral retractor.
Get started
Create a free account to read the full story.